首页|选择性钙通道拮抗剂辅助治疗对溃疡性结肠炎患者血清炎性因子及肠道菌群的影响研究

选择性钙通道拮抗剂辅助治疗对溃疡性结肠炎患者血清炎性因子及肠道菌群的影响研究

扫码查看
目的:探索选择性钙通道拮抗剂(SCCBs)辅助治疗对溃疡性结肠炎(UC)患者血清炎性因子及肠道菌群的影响.方法:选取2018年2月—2020年3月河南大学第一附属医院收治的86例UC患者作为研究对象,采用区组随机化法分为参照组与试验组,每组各43例.参照组予以常规治疗,试验组在参照组基础上予以相应的SCCBs辅助治疗,比较两组患者治疗前后的血清炎性因子[白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]水平、肠道菌群水平及超氧化物歧化酶(SOD)、丙二醛(MDA)水平.结果:治疗后,两组患者IL-6、IL-8、CRP及TNF-α水平均有所降低,且试验组患者IL-6、IL-8、CRP及TNF-α水平均显著低于参照组,差异有统计学意义(t= 6.735、8.374、7.518、6.840,P<0.05).治疗后,两组患者乳酸菌、肠球菌及双歧杆菌水平均有所提升,且试验组患者乳酸菌、肠球菌及双歧杆菌水平均显著高于参照组,差异有统计学意义(t=9.612、9.381、6.187,P<0.05).治疗后,试验组患者SOD水平显著高于参照组,差异有统计学意义(t=7.549,P<0.05),试验组患者MDA水平显著低于参照组,差异有统计学意义(t=9.835,P<0.05).结论:SCCBs辅助治疗应用于UC患者中,能够有效缓解患者的机体炎性反应,调节其肠道菌群,促进其结肠正常生理功能的恢复.
Study of the Effect of Adjuvant Therapy with Selective Calcium Channel Antagonists on Serum Inflammatory Fac-tors and Intestinal Flora in Patients with Ulcerative Colitis
Objective:To explore the effects of adjuvant therapy with selective calcium channel blockers(SCCBs)on serum inflammatory factors and intestinal flora in patients with ulcerative colitis(UC).Methods:86 cases of UC patients admitted to the hospital from February 2018 to March 2020 were selected as the study subjects,and were divided into the reference group and the experimental group using the method of district group randomization,with 43 cases in each group.The reference group was treated with conventional therapy,and the experimental group was treated with appropriate SCCBs on the basis of the reference group.The serum inflammatory factor levels,intestinal flora levels and therapeutic efficacy of the two groups were compared before and after treatment.Results:After treatment,the levels of IL-6,IL-8,CRP and TNF-α were reduced in both groups,but the levels of IL-6,IL-8,CRP and TNF-α in the experimental group were significantly lower than those in the reference group,and the difference was statistically significant(t=6.735,8.374,7.518,6.840,P<0.05).After treatment,the levels of lactobacilli,enterococci and bifidobacteria increased in both groups,but the levels of lactobacilli,enterococci and bifidobacteria in the experimental group were significantly higher than those in the reference group,and the difference was statistically significant(t= 9.612,9.381,6.187,P<0.05).After treatment,the SOD level of the test group was significantly higher than that of the reference group,and the difference was statistically significant(t=7.549,P<0.05).The MDA level of the test group was significantly lower than that of the reference group,and the difference was statistically significant(t=9.835,P<0.05).Conclusion:SCCBs adjuvant therapy applied in UC patients can effectively alleviate the patients'body inflammatory response,regulate their intestinal flora,and promote the recovery of their normal physiological function of the colon.

Ulcerative colitisSelective calcium channel antagonistsAdjuvant therapySerum inflammatory factorsIntestinal flora

魏方圆、范智博、仝甲钊

展开 >

河南大学第一附属医院,河南 开封 475000

溃疡性结肠炎 选择性钙通道拮抗剂 辅助治疗 血清炎性因子 肠道菌群

开封市科技发展项目

1903099

2024

黑龙江医学
中华医学会黑龙江分会

黑龙江医学

影响因子:0.714
ISSN:1004-5775
年,卷(期):2024.48(2)
  • 10